<p>KORU Medical Systems, Inc.（納斯達克代碼：KRMD - 獲取免費報告）目前獲得了六家評級機構的 “適度買入” 共識評級，Marketbeat 報道稱。一位研究分析師給予該股票賣出評級，一位給予持有評級，三位給予買入評級，還有一位給予強烈買入評級。在過去一年中，發佈報告的分析師對該股票的平均一年目標價為 5.1250 美元。</p>
<p>多位研究分析師最近對該公司進行了評論。Canaccord Genuity Group 在週三對 KORU Medical Systems 設定了 6.00 美元的目標價，並給予該股票 “買入” 評級。Weiss Ratings 在 10 月 8 日的報告中重申了對 KORU Medical Systems 股票的 “賣出（d-）” 評級。</p>
<p>獲取 <strong>KORU Medical Systems</strong> 的提醒：</p>
<p><strong>獲取我們關於 KORU Medical Systems 的最新股票報告</strong></p>
<h2>KORU Medical Systems 股票下跌 5.3%</h2>
<p>KRMD 股票在週三下跌 0.31 美元，報 5.47 美元。該公司的股票交易量為 49,708 股，而其平均交易量為 172,944 股。該公司的 50 日移動平均價格為 4.66 美元，200 日移動平均價格為 4.03 美元。KORU Medical Systems 的 52 周低點為 1.86 美元，52 周高點為 6.11 美元。該公司的速動比率為 1.92，流動比率為 2.48，債務與股本比率為 0.01。該公司的市值為 2.5314 億美元，市盈率為-68.31，貝塔值為 0.58。</p>
<h2>機構投資者對 KORU Medical Systems 的看法</h2>
<p>對沖基金和其他機構投資者最近買賣了該公司的股票。Connor Clark &amp; Lunn Investment Management Ltd. 在第一季度將其在 KORU Medical Systems 的持股增加了 11.8%。Connor Clark &amp; Lunn Investment Management Ltd. 現在擁有 66,917 股該公司的股票，價值 170,000 美元，在此期間又購買了 7,046 股。HighTower Advisors LLC 在第一季度將其在 KORU Medical Systems 的持股增加了 18.4%。HighTower Advisors LLC 現在擁有 51,400 股該公司的股票，價值 131,000 美元，在上個季度又收購了 8,000 股。Russell Investments Group Ltd. 在第一季度將其在 KORU Medical Systems 的持股增加了 220.5%。Russell Investments Group Ltd. 現在擁有 214,908 股該公司的股票，價值 546,000 美元，在此期間又收購了 147,857 股。OMERS ADMINISTRATION Corp 在第一季度收購了 KORU Medical Systems 的新股份，價值約 239,000 美元。最後，Cubist Systematic Strategies LLC 在第一季度將其在 KORU Medical Systems 的持股增加了 927.4%。Cubist Systematic Strategies LLC 現在擁有 77,280 股該公司的股票，價值 196,000 美元，在上個季度又收購了 69,758 股。機構投資者持有該公司 58.60% 的股票。</p>
<h2>KORU Medical Systems 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>KORU Medical Systems, Inc. 在美國和國際上開發和製造醫療設備和用品。它提供自由輸注系統，以向患有慢性疾病的患者提供救命療法，例如原發性免疫缺陷疾病、慢性炎性脱髓鞘多發性神經病和陣發性夜間血紅蛋白尿。</p>
<h2>特色文章</h2>
<ul>
<li>五隻我們更看好的股票，而不是 KORU Medical Systems</li>
<li>股票平均計算器</li>
<li>Upwork 能否維持其復甦？看漲和看跌的理由</li>
<li>如何利用高貝塔股票最大化投資利潤</li>
<li>特斯拉被高估了嗎？可能是便宜貨的兩個理由</li>
<li>什麼是股息挑戰者？</li>
<li>這兩隻股票如何贏得 2025 年的人工智能競賽——2026 年又將如何</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9S1JNRA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9S1JNRA"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 KORU Medical Systems 嗎？</h2>
<p>在你考慮 KORU Medical Systems 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 KORU Medical Systems 並不在名單上。</p>
<p>雖然 KORU Medical Systems 目前在分析師中獲得 “適度買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

KRMD

<p>KORU Medical Systems, Inc.（納斯達克代碼：KRMD）獲得了六家評級公司的 “適度買入” 共識評級。該股票有一個賣出評級，一個持有評級，三個買入評級和一個強烈買入評級。平均一年價格目標為 5.1250 美元。該股票最近交易價格為 5.47 美元，下跌 5.3%。機構投資者持有該公司 58.60% 的股票。KORU Medical Systems 開發和製造醫療設備及用品</p>

<p>KORU Medical Systems, Inc. (NASDAQ:KRMD - Get Free Report) has been given a consensus rating of &#34;Moderate Buy&#34; by the six ratings firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $5.1250.</p>
<div class="lb-trans"><p>KORU Medical Systems, Inc.（納斯達克代碼：KRMD - 獲取免費報告）目前獲得了六家評級機構的 “適度買入” 共識評級，Marketbeat 報道稱。一位研究分析師給予該股票賣出評級，一位給予持有評級，三位給予買入評級，還有一位給予強烈買入評級。在過去一年中，發佈報告的分析師對該股票的平均一年目標價為 5.1250 美元。</p>
</div><p>A number of research analysts recently commented on the company. Canaccord Genuity Group set a $6.00 price target on KORU Medical Systems and gave the stock a &#34;buy&#34; rating in a research report on Wednesday. Weiss Ratings reaffirmed a &#34;sell (d-)&#34; rating on shares of KORU Medical Systems in a report on Wednesday, October 8th.</p>
<div class="lb-trans"><p>多位研究分析師最近對該公司進行了評論。Canaccord Genuity Group 在週三對 KORU Medical Systems 設定了 6.00 美元的目標價，並給予該股票 “買入” 評級。Weiss Ratings 在 10 月 8 日的報告中重申了對 KORU Medical Systems 股票的 “賣出（d-）” 評級。</p>
</div><p>Get <strong>KORU Medical Systems</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>KORU Medical Systems</strong> 的提醒：</p>
</div><p><strong>Get Our Latest Stock Report on KORU Medical Systems</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於 KORU Medical Systems 的最新股票報告</strong></p>
</div><h2>KORU Medical Systems Stock Down 5.3%</h2>
<div class="lb-trans"><h2>KORU Medical Systems 股票下跌 5.3%</h2>
</div><p>Shares of KRMD traded down $0.31 on Wednesday, hitting $5.47. The company's stock had a trading volume of 49,708 shares, compared to its average volume of 172,944. The firm's fifty day moving average price is $4.66 and its 200-day moving average price is $4.03. KORU Medical Systems has a fifty-two week low of $1.86 and a fifty-two week high of $6.11. The company has a quick ratio of 1.92, a current ratio of 2.48 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $253.14 million, a price-to-earnings ratio of -68.31 and a beta of 0.58.</p>
<div class="lb-trans"><p>KRMD 股票在週三下跌 0.31 美元，報 5.47 美元。該公司的股票交易量為 49,708 股，而其平均交易量為 172,944 股。該公司的 50 日移動平均價格為 4.66 美元，200 日移動平均價格為 4.03 美元。KORU Medical Systems 的 52 周低點為 1.86 美元，52 周高點為 6.11 美元。該公司的速動比率為 1.92，流動比率為 2.48，債務與股本比率為 0.01。該公司的市值為 2.5314 億美元，市盈率為-68.31，貝塔值為 0.58。</p>
</div><h2>Institutional Investors Weigh In On KORU Medical Systems</h2>
<div class="lb-trans"><h2>機構投資者對 KORU Medical Systems 的看法</h2>
</div><p>Hedge funds and other institutional investors have recently bought and sold shares of the company. Connor Clark &amp; Lunn Investment Management Ltd. increased its position in shares of KORU Medical Systems by 11.8% during the first quarter. Connor Clark &amp; Lunn Investment Management Ltd. now owns 66,917 shares of the company's stock worth $170,000 after buying an additional 7,046 shares during the period. HighTower Advisors LLC boosted its position in KORU Medical Systems by 18.4% during the first quarter. HighTower Advisors LLC now owns 51,400 shares of the company's stock valued at $131,000 after acquiring an additional 8,000 shares during the last quarter. Russell Investments Group Ltd. grew its holdings in KORU Medical Systems by 220.5% during the 1st quarter. Russell Investments Group Ltd. now owns 214,908 shares of the company's stock worth $546,000 after acquiring an additional 147,857 shares during the period. OMERS ADMINISTRATION Corp acquired a new stake in KORU Medical Systems during the 1st quarter worth about $239,000. Finally, Cubist Systematic Strategies LLC raised its position in shares of KORU Medical Systems by 927.4% in the 1st quarter. Cubist Systematic Strategies LLC now owns 77,280 shares of the company's stock worth $196,000 after acquiring an additional 69,758 shares in the last quarter. Institutional investors own 58.60% of the company's stock.</p>
<div class="lb-trans"><p>對沖基金和其他機構投資者最近買賣了該公司的股票。Connor Clark &amp; Lunn Investment Management Ltd. 在第一季度將其在 KORU Medical Systems 的持股增加了 11.8%。Connor Clark &amp; Lunn Investment Management Ltd. 現在擁有 66,917 股該公司的股票，價值 170,000 美元，在此期間又購買了 7,046 股。HighTower Advisors LLC 在第一季度將其在 KORU Medical Systems 的持股增加了 18.4%。HighTower Advisors LLC 現在擁有 51,400 股該公司的股票，價值 131,000 美元，在上個季度又收購了 8,000 股。Russell Investments Group Ltd. 在第一季度將其在 KORU Medical Systems 的持股增加了 220.5%。Russell Investments Group Ltd. 現在擁有 214,908 股該公司的股票，價值 546,000 美元，在此期間又收購了 147,857 股。OMERS ADMINISTRATION Corp 在第一季度收購了 KORU Medical Systems 的新股份，價值約 239,000 美元。最後，Cubist Systematic Strategies LLC 在第一季度將其在 KORU Medical Systems 的持股增加了 927.4%。Cubist Systematic Strategies LLC 現在擁有 77,280 股該公司的股票，價值 196,000 美元，在上個季度又收購了 69,758 股。機構投資者持有該公司 58.60% 的股票。</p>
</div><h2>KORU Medical Systems Company Profile</h2>
<div class="lb-trans"><h2>KORU Medical Systems 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.</p>
<div class="lb-trans"><p>KORU Medical Systems, Inc. 在美國和國際上開發和製造醫療設備和用品。它提供自由輸注系統，以向患有慢性疾病的患者提供救命療法，例如原發性免疫缺陷疾病、慢性炎性脱髓鞘多發性神經病和陣發性夜間血紅蛋白尿。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>特色文章</h2>
</div><ul>
<li>Five stocks we like better than KORU Medical Systems</li>
<li>Stock Average Calculator</li>
<li>Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish</li>
<li>How to Use High Beta Stocks to Maximize Your Investing Profits</li>
<li>Is Tesla Overvalued? 2 Reasons It Might Be a Bargain</li>
<li>What Are Dividend Challengers?</li>
<li>How These 2 Stocks Won 2025's AI Race—And What's In Store for 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，而不是 KORU Medical Systems</li>
<li>股票平均計算器</li>
<li>Upwork 能否維持其復甦？看漲和看跌的理由</li>
<li>如何利用高貝塔股票最大化投資利潤</li>
<li>特斯拉被高估了嗎？可能是便宜貨的兩個理由</li>
<li>什麼是股息挑戰者？</li>
<li>這兩隻股票如何贏得 2025 年的人工智能競賽——2026 年又將如何</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9S1JNRA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=KRMD"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in KORU Medical Systems Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 KORU Medical Systems 嗎？</h2>
</div><p>Before you consider KORU Medical Systems, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 KORU Medical Systems 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KORU Medical Systems wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 KORU Medical Systems 並不在名單上。</p>
</div><p>While KORU Medical Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 KORU Medical Systems 目前在分析師中獲得 “適度買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

分析師給予 KORU Medical Systems, Inc. (NASDAQ:KRMD)“適度買入” 的平均推薦